Osaic Holdings’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$492K Buy
98,130
+3,130
+3% +$15.7K ﹤0.01% 2826
2025
Q1
$162K Sell
95,000
-2,129
-2% -$3.64K ﹤0.01% 3797
2024
Q4
$490K Buy
97,129
+19,817
+26% +$100K ﹤0.01% 2814
2024
Q3
$421K Buy
77,312
+26,777
+53% +$146K ﹤0.01% 3042
2024
Q2
$243K Buy
50,535
+3,455
+7% +$16.6K ﹤0.01% 3386
2024
Q1
$146K Buy
47,080
+6,555
+16% +$20.4K ﹤0.01% 3936
2023
Q4
$115K Buy
40,525
+925
+2% +$2.63K ﹤0.01% 4332
2023
Q3
$116K Buy
39,600
+5,615
+17% +$16.5K ﹤0.01% 4396
2023
Q2
$97.2K Buy
33,985
+4,775
+16% +$13.7K ﹤0.01% 4456
2023
Q1
$90.4K Buy
29,210
+1,481
+5% +$4.58K ﹤0.01% 4529
2022
Q4
$58K Buy
27,729
+825
+3% +$1.73K ﹤0.01% 4814
2022
Q3
$88K Buy
26,904
+50
+0.2% +$164 ﹤0.01% 4475
2022
Q2
$86K Buy
26,854
+1,834
+7% +$5.87K ﹤0.01% 4532
2022
Q1
$177K Buy
25,020
+4,946
+25% +$35K ﹤0.01% 4138
2021
Q4
$146K Buy
20,074
+1,850
+10% +$13.5K ﹤0.01% 4236
2021
Q3
$211K Buy
18,224
+5,674
+45% +$65.7K ﹤0.01% 3847
2021
Q2
$128K Buy
12,550
+11,550
+1,155% +$118K ﹤0.01% 4260
2021
Q1
$11K Buy
+1,000
New +$11K ﹤0.01% 5787